Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia

Pobierz rekord bibliograficzny (.ris)

TABLE WITHOUT ID
  this.creators AS "Autor / redaktor",
  this.title AS "Tytuł",
  this.itemType AS "Typ",
  this.publication AS "Publikacja",
  this.year AS "Rok",
  this.doi AS "DOI",
  this.url AS "URL"
WHERE file.path = this.file.path

Abstract

Background and aim: Rivastigmine is now widely approved for the treatment of mild to moderately severe dementia in Parkinson’s disease (PDD). However, since anticholinergic drugs have a role in the management of tremor in patients with Parkinson’s disease (PD), concerns have been raised that the use of cholinergic drugs might worsen PD. The current analyses were performed to examine the potential of rivastigmine to affect tremor and other motor symptoms in patients with PDD.

Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia

Abstract

Notes